0001140361-23-036386.txt : 20230727 0001140361-23-036386.hdr.sgml : 20230727 20230727090412 ACCESSION NUMBER: 0001140361-23-036386 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230727 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230727 DATE AS OF CHANGE: 20230727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FEMASYS INC CENTRAL INDEX KEY: 0001339005 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113713499 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40492 FILM NUMBER: 231115441 BUSINESS ADDRESS: STREET 1: 3950 JOHNS CREEK COURT STREET 2: SUITE 100 CITY: SUWANEE STATE: GA ZIP: 30024 BUSINESS PHONE: 770-500-3910 MAIL ADDRESS: STREET 1: 3950 JOHNS CREEK COURT STREET 2: SUITE 100 CITY: SUWANEE STATE: GA ZIP: 30024 8-K 1 brhc20056471_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 27, 2023

Femasys Inc.
(Exact name of registrant as specified in its charter)

Delaware
001-40492
11-3713499
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

3950 Johns Creek Court, Suite 100
  
Suwanee, Georgia
   30024
(Address of principal executive offices)
  
(Zip Code)

(770) 500-3910
(Registrant’s telephone number, including area code)

n/a
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
  
Trading
Symbol(s)
  
Name of each
exchange
on which registered
Common Stock, par value $0.001 per share
   FEMY
  
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 8.01
Other Events

On July 27, 2023, Femasys Inc. (the “Company”) announced notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits.

Exhibit
No.
Description
   
Press Release of Femasys Inc. dated July 27, 2023.

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Femasys Inc.
   
 
By:
/s/ Kathy Lee-Sepsick
 
Names: Kathy Lee-Sepsick
 
Title: Chief Executive Officer
   
Date: July 27, 2023
  



EX-99.1 2 brhc20056471_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control
 
- FemBloc® patent application provides additional coverage for Femasys’
therapeutic option for women seeking permanent birth control -
 
ATLANTA, July 27, 2023 – Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting women’s unmet needs worldwide by developing a suite of product candidates and products that include minimally invasive, in-office technologies for reproductive health, announced that the United States Patent and Trademark Office (“USPTO”) issued a Notice of Allowance for U.S. Patent Application 16/402,193 further strengthening Femasys’ intellectual property position and coverage for the Company’s therapeutic product candidate, FemBloc® permanent birth control.
 
Femasys expects the resulting patent, when issued, will have an anticipated expiration in 2039 at the earliest. Femasys intends to continue to prosecute additional patent applications to further enhance its existing patent portfolio protecting FemBloc along with FemaSeed® localized directional insemination for infertility treatment, representing the two lead product candidates of the Company, in addition to the Company’s existing available diagnostic products, FemVue®, FemCath®, and FemCerv®.
 
“The allowance of claims for the FemBloc permanent birth control is another important milestone in protecting the commercial potential for this novel, non-surgical contraceptive option for women seeking a permanent birth control solution, which is expected to begin its pivotal clinical trial phase this quarter,” stated Kathy Lee-Sepsick, Femasys’ founder, president and chief executive officer. “Expansion of our patent portfolio, which consists of over 150 patents globally, demonstrates our strong commitment to protecting the innovation and commercial opportunity of FemBloc, as well as our entire suite of products for women seeking better and more accessible options.”
 
About FemBloc

FemBloc® is a first-of-its-kind, nonsurgical, non-implant, in-office solution in its late-stage of clinical development for permanent birth control. It is intended to be a safer option for women estimated at approximately half the cost of the long-standing surgical alternative by eliminating the need for anesthesia, incisions, and permanent implants. FemBloc has the potential to offer women a convenient, accessible, and reliable option for those seeking permanent birth control. For over 100 years there has been stagnant innovation for permanent birth control which could lead to a $20 billion market expansion opportunity for FemBloc in the U.S. alone. For more information, visit www.FemBloc.com.

About Femasys
 
Femasys Inc. is a biomedical company focused on meeting women's unmet needs worldwide by developing a suite of product candidates and products that include minimally invasive, in-office technologies for reproductive health. Its two lead product candidates in late-stage clinical development are FemBloc® permanent birth control and FemaSeed® localized directional insemination for infertility. The Company’s diagnostic products currently available in the United States, include FemVue® for fallopian tube assessment by ultrasound, which can be used in conjunction with FemCath®, an intrauterine catheter for selective fallopian tube evaluation, and FemCerv®, an endocervical tissue sampler for cervical cancer diagnosis. FemaSeed, FemCerv, and FemCath have also received product approval in Canada. To learn more, visit www.Femasys.com or follow us on Twitter, Facebook and LinkedIn.
 
Forward-Looking Statements
This press release contains forward-looking statements that are subject to substantial risks and uncertainties. Forward-looking statements can be identified by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “pending,” “intend,” “believe,” “potential,” “hope,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on our current expectations and are subject to inherent uncertainties, risks and assumptions, many of which are beyond our control, difficult to predict and could cause actual results to differ materially from what we expect. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ include, among others: our ability to develop and advance our current product candidates and programs into, and successfully initiate, enroll and complete, clinical trials; the ability of our clinical trials to demonstrate safety and effectiveness of our product candidates and other positive results; estimates regarding the total addressable market for our product candidates; our business model and strategic plans for our products, technologies and business, including our implementation thereof; and those other risks and uncertainties described in the section titled "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other reports as filed with the SEC. Forward-looking statements contained in this press release are made as of this date, and Femasys undertakes no duty to update such information except as required under applicable law.

Contacts:
Investors
Chuck Padala
LifeSci Advisors, LLC
+1-917-741-7792
chuck@lifesciadvisors.com

Femasys Inc.
Investor Contact:
IR@femasys.com

Media Contact:
Media@femasys.com


 EX-101.SCH 3 femy-20230727.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 femy-20230727_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 femy-20230727_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information
Jul. 27, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 27, 2023
Entity File Number 001-40492
Entity Registrant Name Femasys Inc.
Entity Central Index Key 0001339005
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 11-3713499
Entity Address, Address Line One 3950 Johns Creek Court
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Suwanee
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30024
City Area Code 770
Local Phone Number 500-3910
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol FEMY
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period true
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 7 brhc20056471_8k_htm.xml IDEA: XBRL DOCUMENT 0001339005 2023-07-27 2023-07-27 false 0001339005 8-K 2023-07-27 Femasys Inc. DE 001-40492 11-3713499 3950 Johns Creek Court Suite 100 Suwanee GA 30024 770 500-3910 false false false false Common Stock, par value $0.001 per share FEMY NASDAQ true true EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 24 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://femasys.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc20056471_8k.htm brhc20056471_ex99-1.htm femy-20230727.xsd femy-20230727_lab.xml femy-20230727_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc20056471_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "brhc20056471_8k.htm" ] }, "labelLink": { "local": [ "femy-20230727_lab.xml" ] }, "presentationLink": { "local": [ "femy-20230727_pre.xml" ] }, "schema": { "local": [ "femy-20230727.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "femy", "nsuri": "http://femasys.com/20230727", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20056471_8k.htm", "contextRef": "c20230727to20230727", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://femasys.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20056471_8k.htm", "contextRef": "c20230727to20230727", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://femasys.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001140361-23-036386-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-23-036386-xbrl.zip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